In our previous study, the results of ELISA inhibition experiments indicated that the DpTTDp vaccine had a considerable capability to inhibit the binding of IgE antibodies to allergens in sera obtained from patients with an HDM allergy. The gene discussed is IGHE; the disease is Allergy.